Abstract: Water is used to control particle size in a process comprising mixing water with a composition comprising a rheology modifying agent and possibly sugar and cellulose to produce a paste. The paste is extruded to form particles which are then spheronised and dried. One advantage of using water to control particle size is that the number of particles having a diameter within a required range, e.g. between from about 800 to about 1500 ?m, may be increased.

Abstract: Water is used to control particle size in a process comprising mixing water with a composition comprising a rheology modifying agent and possibly sugar and cellulose to produce a paste. The paste is extruded to form particles which are then spheronised and dried. One advantage of using water to control particle size is that the number of particles having a diameter within a required range, e.g. between from about 800 to about 1500 ?m, may be increased.

Abstract: Water is used to control particle size in a process comprising mixing water with a composition comprising a rheology modifying agent and possibly sugar and cellulose to produce a paste. The paste is extruded to form particles which are then spheronised and dried. One advantage of using water to control particle size is that the number of particles having a diameter within a required range, e.g. between from about 800 to about 1500 ?m, may be increased.

Abstract: A therapeutically effective amount of at least one phosphoenolpyruvate derivative having Formula (1): wherein: X is selected from the group consisting of O; and NH; Y is selected from the group consisting of OH; OR1; and NR2R3; Z1 and Z2 are selected, independently, from the group consisting of OH; OR4; and NR5R6; and wherein: R1 to R6 are selected, independently, from the group consisting of H; alkyl; cycloalkyl; alkenyl; aryl; and aralkyl, or a physiologically acceptable salt thereof is administered to a patient to reduce or inhibit necrosis of cardiac muscle tissue as evidenced by a reduction in the levels of cardiac troponins in the blood. A particularly preferred derivative is phosphoenolpyruvic amide (“PEPA”), i.e. wherein X?O; Y?NH2; and Z1=Z2=OH.

Abstract: Water is used to control particle size in a process comprising mixing water with a composition comprising a rheology modifying agent and possibly sugar and cellulose to produce a paste. The paste is extruded to form particles which are then spheronised and dried. One advantage of using water to control particle size is that the number of particles having a diameter within required range, e.g. between from about 800 to about 1500 ?m, may be increased.

Abstract: The present invention concerns generally passive matrix displays, in particular a display device and a method for driving a display device.

Abstract: A display device (1) comprising: a liquid crystal display (2) having pixels (8) which are arranged in columns C and rows R; and a gate driving arrangement (4) for activating the pixels (8) of rows (R) in dependence on a row scanning scheme; a source driving arrangement (3) for providing column voltages representing the respective image data, a number of buffers (40) depending on the number of grey levels for supplying the respective voltage levels to the columns (C), a switching unit (31) for selecting a voltage level which corresponds to the grey level to be displayed; and a control unit (32) for controlling the buffers (40). For reducing the power consumption, an analyzing unit (39) is provided which analyzes the image data to be displayed such that the control unit (32) can determine the number of required buffers in dependence on the number of grey levels to be displayed and can switch off any unused buffers.

Abstract: An improved composition for controlling the release profile of an active compound through the intestinal tract comprises particles, especially pellets, containing the active compound, which are coated with a pH dissolution dependent coating material or a polymethacrylate material, which is preferably pH dissolution dependent, to a certain thickness depending upon the location and rate of release of the active compound that is desired. In preferred compositions, two or more pluralities of particles, in which particles of each plurality are coated with pH dissolution dependent coating material or polymethacrylate material to a different thickness to those of each other plurality, are contained within an enterically coated capsule and provide release of the active compound at various desired locations in the intestinal tract.

Abstract: The invention relates to a circuit arrangement for controlling a display device (2) which can be operated in a partial mode, comprising a row drive circuit (4) for driving n rows of the display device (2) and a column drive circuit (3) for driving m columns of the display device, wherein the row drive circuit (4) controls the n rows of the display device sequentially from 1 to n, and the column drive circuit (3) supplies column voltages to the m columns, which voltages correspond to the picture data to be displayed of pixels of the controlled row. The invention further relates to a display device with such a circuit arrangement, a row drive circuit for a display device, an electronic appliance with a display device, and a method of realizing a partial mode.

Abstract: The invention relates to a voltage processing unit comprising an integrated charge pump 11 for multiplying a voltage Vx applied to an input of the integrated charge pump 11 by a predetermined factor Xm. In order to enable a multiplication of an available voltage by a desired factor with a reduced required area for the integrated charge pump, it is proposed that the voltage processing unit further comprises an external voltage doubling circuit 12 for amplifying an available voltage Vdd and for applying the amplified voltage Vx to the input of the integrated charge pump 11. The invention relates equally to a corresponding method.